RELATED STUDY
Cannabidiol Supplements in Romania: Bridging the Gap Between Marketed Claims and Clinical Reality
Key Findings: This systematic review identified cannabidiol- (CBD) based products available for sale online in Romania. Additionally, some claims lack substantial clinical evidence, such as those related to post-traumatic stress disorder. The dosages recommended were often significantly lower than those used in trials.
Type of Study: Meta-analysis
Study Sample Size: 76
Study Result: Inconclusive
Research Location(s): Romania
Year of Pub: 2024
Cannabinoids Studied: Cannabidiol (CBD), Pharma THC:CBD, Pharma CBD
Phytocannabinoid Source: Not Applicable
Route of Administration: Nasal, Oral (Ingestion), Sublingual/Oromucosal
Cannabinoid Ratio: (CBD) 0 
Dosage Form: oils with CBD concentrations between 5 and 40% (0.5–3 g/10 mL)
Citation: Andrei C, Nitulescu GM, Nitulescu G, Zanfirescu A. Cannabidiol Supplements in Romania: Bridging the Gap Between Marketed Claims and Clinical Reality. Pharmacy (Basel). 2024 Nov 25;12(6):176. doi: 10.3390/pharmacy12060176. PMID: 39728841; PMCID: PMC11676264.
